MCQ: Hematopathology

30 clinical MCQs in Hematopathology. What percentage of Non-Hodgkin Lymphomas are of B-cell origin?. Kenya, Africa and global revision.

Questions, Answers & Explanations

  1. Q1. What percentage of Non-Hodgkin Lymphomas are of B-cell origin?

    Answer: 85%

    Explanation: NHL is 85% B-cell and 15% T/NK-cell origin. This is a foundational fact frequently tested. ---

  2. Q2. Which is the most common subtype of B-cell NHL?

    Answer: Diffuse large B-cell lymphoma

    Explanation: DLBCL is the most common NHL subtype overall. Follicular is second at 29%. ---

  3. Q3. A 60-year-old woman has widespread painless lymphadenopathy. Biopsy shows BCL-2+, CD10+, CD20+ cells. The disease has been present for years with slow progression. What is the most likely diagnosis?

    Answer: Follicular lymphoma

    Explanation: Indolent course + BCL-2+/CD10+ markers + t(14;18) = classic follicular lymphoma presentation. ---

  4. Q4. Which translocation is required for the diagnosis of Mantle Cell Lymphoma?

    Answer: t(11;14)

    Explanation: This juxtaposes the Cyclin D1 gene to the Ig heavy-chain gene → Cyclin D1 overexpression. Its presence is required for MCL diagnosis. ---

  5. Q5. A patient with NHL has CD5+, CD19+, CD22+, CD23− immunophenotype. Which lymphoma does this suggest?

    Answer: Mantle cell lymphoma

    Explanation: Both MCL and CLL are CD5+/CD19+, but MCL is CD23− while CLL is CD23+. CD22+ also favours MCL. ---

  6. Q6. Which organism is directly implicated in the pathogenesis of gastric MALT lymphoma?

    Answer: Helicobacter pylori

    Explanation: Gastric MALT lymphoma is strongly linked to H. pylori. Early-stage disease can regress completely with antibiotics alone. ---

  7. Q7. What is the first-line treatment for early-stage gastric MALT lymphoma?

    Answer: H. pylori eradication with antibiotics

    Explanation: In early-stage gastric MALT, eliminating H. pylori can be curative. Chemotherapy is reserved for advanced or refractory disease. ---

  8. Q8. A 55-year-old man presents with visual disturbances, fatigue and epistaxis. Serum protein electrophoresis shows a monoclonal IgM spike. Bone marrow biopsy reveals lymphoplasmacytoid infiltration. What gene mutation is present in 90% of cases?

    Answer: MYD88

    Explanation: This is Waldenström's macroglobulinaemia (LPL). MYD88 mutation is present in 90% and is near-diagnostic. ---

  9. Q9. Why is plasmapheresis particularly effective in treating hyperviscosity in Waldenström's macroglobulinaemia compared to IgG myeloma?

    Answer: IgM is mainly intravascular, making it accessible to plasmapheresis

    Explanation: Because IgM stays in the bloodstream (unlike IgG which redistributes extravascularly), plasmapheresis efficiently removes it and rapidly relieves hyperviscosity. ---

  10. Q10. A child from sub-Saharan Africa presents with a rapidly growing jaw mass. EBV is detected. Histology shows a 'starry sky' pattern with 95% proliferative index. What is the diagnosis?

    Answer: Endemic Burkitt lymphoma

    Explanation: Jaw mass + EBV + malaria-endemic region + starry sky histology + 95% mitotic index = classic endemic Burkitt. Translocation is t(8;14) → MYC overexpression. ---

  11. Q11. Which oncogene is overexpressed in virtually all cases of Burkitt lymphoma?

    Answer: MYC

    Explanation: t(8;14) translocates MYC to the Ig heavy-chain locus → constitutive MYC expression during phases it should be OFF → uncontrolled proliferation. ---

  12. Q12. What is the gold standard investigation for diagnosing NHL?

    Answer: Trucut / whole lymph node biopsy

    Explanation: FNA is specifically insufficient for NHL diagnosis. A biopsy providing tissue architecture is essential for accurate histological subtyping. ---

  13. Q13. A 45-year-old HIV-positive patient develops a brain mass. MRI shows a ring-enhancing lesion. Biopsy confirms large B-cells with prominent nucleoli. What is the most likely diagnosis?

    Answer: Primary CNS lymphoma

    Explanation: Primary CNS lymphoma is more common in elderly and HIV+ patients. It is usually DLBCL type. Treat with high-dose methotrexate + cytosine arabinoside. ---

  14. Q14. What is the standard first-line treatment for DLBCL?

    Answer: R-CHOP × 6–8 cycles

    Explanation: R-CHOP (Rituximab + Cyclophosphamide + Hydroxydaunorubicin + Vincristine + Prednisolone) given every 3 weeks is the backbone of DLBCL treatment. ---

  15. Q15. Which subtype of DLBCL carries a worse prognosis?

    Answer: Activated B-cell (ABC) type

    Explanation: ABC type stains MUM1+ and activates the NFκB pathway. It has a worse prognosis compared to GCB type which stains BCL-6+. ---

  16. Q16. A 35-year-old patient is diagnosed with lymphoma. Biopsy reveals TdT-positive cells. The presentation overlaps significantly with acute lymphoblastic leukaemia. What is the diagnosis?

    Answer: Lymphoblastic lymphoma

    Explanation: TdT (terminal deoxynucleotidyl transferase) positivity is the hallmark of lymphoblastic lymphoma — it is negative in ALL other NHL types. Treated with ALL protocols. ---

  17. Q17. Which virus is associated with Adult T-cell Leukaemia/Lymphoma?

    Answer: HTLV-1

    Explanation: Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of Adult T-cell Leukaemia/Lymphoma. This is a must-know association. ---

  18. Q18. A 70-year-old woman presents with skin rash, hepatosplenomegaly, lymphadenopathy and a polyclonal rise in IgG. What is the diagnosis?

    Answer: Angioimmunoblastic T-cell lymphoma

    Explanation: Key triad: lymphadenopathy + hepatosplenomegaly + skin rash + polyclonal IgG in an an elderly patient. Treated with chemotherapy or histone deacetylase inhibitors. ---

  19. Q19. A patient presents with severe pruritus and psoriasis-like skin plaques. Years later they develop lymph node and bone marrow involvement. What is the diagnosis?

    Answer: Mycosis fungoides

    Explanation: Mycosis fungoides is a chronic cutaneous T-cell lymphoma starting with pruritus and skin plaques, eventually spreading to deeper organs. Treatment is phototherapy. ---

  20. Q20. What distinguishes Sézary syndrome from Mycosis fungoides on blood film?

    Answer: Circulating T-lymphoma cells with cerebriform nuclei

    Explanation: Sézary syndrome = Sézary cells (CD4+ T-cells with cerebriform nuclei) in the blood + erythroderma + lymphadenopathy. This is pathognomonic. ---

  21. Q21. Which lymphoma is most strongly associated with coeliac disease?

    Answer: Enteropathy-associated T-cell lymphoma (EATL)

    Explanation: EATL arises as a complication of coeliac disease and carries a very poor prognosis with poor treatment response. ---

  22. Q22. Which serum marker is the most important prognostic indicator in NHL?

    Answer: Serum LDH

    Explanation: Elevated LDH reflects rapid tumour proliferation and high disease burden. It is a key component of the IPI and NCCN-IPI prognostic scoring systems. ---

  23. Q23. A patient with follicular lymphoma is Stage III but completely asymptomatic. What is the recommended management?

    Answer: Watch and wait

    Explanation: Stage II–IV asymptomatic follicular lymphoma is managed with watch and wait. Treatment begins only when symptoms or complications develop. ---

  24. Q24. What is the ONLY curative option for follicular lymphoma?

    Answer: Allogeneic SCT

    Explanation: Chemotherapy can achieve remission but is not curative in follicular lymphoma. Allogeneic SCT offers the only prospect of cure via graft-vs-lymphoma effect. ---

  25. Q25. Anaplastic Large Cell Lymphoma (ALCL) is associated with which translocation and its resulting overexpressed protein?

    Answer: t(2;5) → ALK

    Explanation: t(2;5) causes overexpression of anaplastic lymphoma kinase (ALK). ALK+ ALCL has better prognosis than ALK− ALCL. Crizotinib specifically inhibits ALK. ---

  26. Q26. What is the mechanism by which the t(14;18) translocation in follicular lymphoma promotes tumour survival?

    Answer: BCL-2 overexpression prevents apoptosis

    Explanation: t(14;18) brings BCL-2 under the Ig heavy-chain promoter → constitutive BCL-2 expression → cells survive longer than they should → lymphoma. ---

  27. Q27. Which BRAF mutation is present in 99% of Hairy Cell Leukaemia cases?

    Answer: BRAF V600E

    Explanation: BRAF V600E mutation is present in 99% of hairy cell leukaemia cases, making it both diagnostic and a therapeutic target (vemurafenib). ---

  28. Q28. In the NCCN-IPI for high-grade NHL, which factor carries the highest score?

    Answer: Age >75 years

    Explanation: In the NCCN-IPI: Age 75 = 3 points, the highest single score. LDH 3× normal = 2 points. All other factors = 1 point each. ---

  29. Q29. A patient with relapsed DLBCL responds to R-ICE salvage chemotherapy. What is the next step?

    Answer: Autologous stem cell transplantation

    Explanation: In DLBCL patients who respond to salvage chemotherapy (R-ICE), autologous SCT consolidates the response and offers the best chance of long-term remission. ---

  30. Q30. Which of the following correctly matches the infectious agent to its associated lymphoma?

    Answer: HHV-8 → Primary effusion lymphoma

    Explanation: HHV-8 causes primary effusion lymphoma and multicentric Castleman's disease. H. pylori → gastric MALT. EBV → Burkitt/Hodgkin. HTLV-1 → Adult T-cell leukaemia/lymphoma.

View on OmpathStudy